Bioequivalence and Bioavailability Forum

Dear Sir,

At the outset I wish each one of you a very Happy, Healthy and Prosperous New Year ahead.

I have one question about the study design. I would highly appreciate if you could help me understand the design issue for a FDA submission study. Can we have a different study design for fast and fed study in the same set of studies. For e.g. planning one of the studies as 3 WC and another one as 2 WC?

If yes, then could you please explain the rational.

Thanks in advance.

Yours,

ABP